BioCentury
ARTICLE | Clinical News

Topical NS2: Phase II data

August 15, 2016 7:00 AM UTC

A double-blind, U.S. Phase II trial in 12 Sjogren-Larsson syndrome patients with moderate to severe ichthyosis showed that once-daily 1% topical NS2 administered on a 4x10 inch area of skin for 2 mont...